Close Menu

NEW YORK (GenomeWeb) – Belgian diagnostics firm OncoDNA said today that it has signed an agreement under which its tumor profiling products and services will be offered in the Russian Federation by Genext.

Under the deal, Genext will market and distribute OncoDNA's OncoDeep solid tumor test; its OncoTrace and OncoSelect liquid biopsy tests; its OncoStrat&Go solid and liquid biopsy combination; and its OncoKDM data interpretation and reporting software.

Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.